Purchase Order 75D30125P20389

Award Date 11/22/24
Potential Completion Date 4/24/25
Potential Value $250K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Petaluma, CA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order to Biosearch Technologies, Inc. for the procurement of 20 Signature polymerase chain reaction (PCR) kits. The award, valued at $242,150.00, leveraged Biosearch Technologies' unique Black Hole Quencher technology, which is required for the production of these PCR reagents and is only licensed by Biosearch. This sole-source award was made under the...
This is a federal contract award to Biosearch Technologies, Inc., a foreign-owned, for-profit manufacturer of oligonucleotide-based tools and laboratory supplies, located in Petaluma, California. The contract is a Blanket Purchase Agreement (BPA) call with the Centers for Disease Control and Prevention (CDC) for $258,768.00 to provide "PRIMER PROBES". The contract is for Firm Fixed Price delivery of the products, with a completion date of December 31, 2023. Biosearch Technologies has a...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
This is a federal contract award to Biosearch Technologies, Inc. (Biosearch) by the Centers for Disease Control and Prevention (CDC) under the BIOSEARCH IDIQ (Indefinite Delivery/Indefinite Quantity) contract vehicle. The contract, valued at $677,800.00, is for the delivery of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a $151,050.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. The contract is for the provision of laboratory supplies including Biosearch PCR kits for Ebola, Rickettsia, and Variola viruses. This contract does not have a set-aside designation. Biosearch Technologies, a privately held manufacturer of oligonucleotide-based tools, has previously held federal contracts...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...
The Centers for Disease Control and Prevention (CDC) awarded a $1,343,205.50 firm fixed-price contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide primer probes. This award was not set aside for any specific business type. Biosearch Technologies has a history of providing laboratory supplies like assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts for federal...

This federal contract award, valued at $249,997.00, was made by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a foreign-owned, for-profit manufacturer of oligonucleotide-based laboratory supplies and diagnostic testing components. The contract is for the provision of polymerase chain reaction (PCR) testing kits, with a period of performance running through April 24, 2025.

Biosearch Technologies has a significant history as a federal contractor, having worked with various agencies like the CDC, Department of Defense, and National Cancer Institute on public health initiatives involving disease surveillance, diagnostic testing, and emergency response efforts. The company holds a $19 million Blanket Purchase Agreement with the CDC, further demonstrating its critical role in supporting the national public health infrastructure through the provision of reagents and diagnostic kits. This contract award did not utilize any set-aside designations, indicating open competition.

Generated 5/28/25, 10:49 AM